Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07254364 · ClinicalTrials.gov registry record · NA
Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring
A NA study of Insulin Response, sponsored by Texas A&M University.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT07254364: Recruiting NA study of Insulin Response, sponsored by Texas A&M University.
NCT07254364 is a NA study of Insulin Response that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07254364, a NA study of Insulin Response, is actively recruiting participants, sponsored by Texas A&M University.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Noninvasively monitoring insulin is crucial for advancing precision nutrition and promoting healthy living by enabling a deeper understanding of individual metabolic responses to dietary intake. Insulin is a key regulator of blood sugar and energy metabolism, and its dysregulation is linked to conditions such as diabetes, obesity, and metabolic syndrome. By noninvasively tracking insulin levels, individuals can gain real-time insights into how their body processes different foods, allowing for the personalization of diets to optimize metabolic health, manage weight, and reduce disease risk. This approach also empowers proactive lifestyle adjustments to maintain insulin sensitivity, improve glycemic control, and enhance overall well-being. Decentralized insulin quantification in biofluids, including saliva and serum, based on lateral flow assay or electrochemical sensor has been reported. However, these approaches have poor sensitivity and fail to quantify insulin with a high temporal resolution.
Primary Outcome
Time-varying plasma insulin concentrations and correlation between sweat and dermal interstitial fluid.
Conditions Studied
Interventions
- OTHER Standardized meal
Study Locations (1)
Texas
- Texas A&M University - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07254364 shows while recruiting
NCT07254364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Insulin Response appearing as the primary indexed condition, and to 1 intervention - of which Standardized meal is the first listed.
NCT07254364 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07254364 about?
NCT07254364 is a clinical study titled "Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring". Noninvasively monitoring insulin is crucial for advancing precision nutrition and promoting healthy living by enabling a deeper understanding of individual metabolic responses to dietary intake. Insulin is a key regulator of blood sugar and energy metabolism, and its dysregulation is linked to condi...
What is the current status of trial NCT07254364?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-09-11. Estimated completion is 2026-12.
What conditions does trial NCT07254364 study?
This clinical trial studies the following conditions: Insulin Response.
What interventions are being tested in trial NCT07254364?
The interventions under investigation include: Standardized meal (OTHER).
Who is sponsoring clinical trial NCT07254364?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07254364 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07254364's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI